| 标题 |
TROPION-Lung15: a randomized phase III study of osimertinib combined with datopotamab deruxtecan (Dato-DXd) or Dato-DXd alone versus platinum-doublet chemotherapy in patients with EGFR -mutated advanced non-small cell lung cancer and whose disease has progressed on prior osimertinib |
| 网址 | |
| DOI | |
| 其它 |
期刊:Therapeutic Advances in Medical Oncology 作者:Daniel Shao‐Weng Tan; Ernest Nadal; Parneet Kaur Cheema; Y. Wu; Myung‐Ju Ahn; et al 出版日期:2025-12-01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人或该文件上传人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)